Duration of Response in a Phase 3 Study of Sarilumab Plus Methotrexate in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis

Author(s):
Genovese, M.C.; Mangan, E.K.; Kimura, T.; Iglesias-Rodriguez, M.; Huizinga, T.W.J. (0000-0001-7033-7520)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-31
Language
English
Is part of
Arthritis and Rheumatology
hdl
1887/116106